When Dr. Jean Kaseya speaks of health sovereignty, he does so not as theory, but as necessity—forged in the clinics of Bundibugyo during the latest Ebola outbreak and in the quiet resilience of 22 million Africans living with HIV who wake up each day because they accessed treatment. Africa’s fight against AIDS has reached a turning point: a 59% drop in AIDS-related deaths since 2010 and a 68% decline in new infections prove progress is possible. But the lifeline that made it happen—external health aid—is fraying. Estimates show a staggering 70% drop in such funding between 2021 and 2025, forcing a reckoning. The era of dependence is ending. Now, Africa is charting its own course.
The Common Africa Position, forged ahead of the 2026 UN High-Level Meeting on HIV/AIDS, is not a plea—it’s a plan. Backed by African heads of state and institutions like Africa CDC and the African Union, it demands a new model: one where health is treated as a sovereign right, not a charitable handout. At its core is finance. Domestic HIV funding has grown over the past decade, but now it must accelerate, embedded in national budgets and universal health coverage systems. Africa CDC has set a clear target: at least 20 African countries must finance half or more of their own health spending by 2030. International partners are still needed, especially for nations in conflict or economic strain, but their support must align with one national plan, one budget, one monitoring system.
Access is the next pillar. For too long, Africa has waited for medicines made thousands of miles away. That changes now. The African Pooled Procurement Mechanism (APPM) is leveraging continental demand to negotiate better prices, while the African Medicines Agency is clearing the path for local production. The goal? To manufacture at least 60% of the continent’s health product needs by 2040. Breakthrough tools like lenacapavir, a long-acting injectable that could reach 9 to 11 million people and dramatically accelerate progress toward ending AIDS by 2030, must be accessible at prices African budgets can sustain—not just donated in bursts that vanish when attention shifts.
Finally, the systems must hold. HIV care must move from siloed programs into integrated primary healthcare, where a mother can access testing, treatment, and maternal care in one visit. Communities living with HIV, who have led this fight from the beginning, must be formally funded and empowered. Data must be African-owned, and rights must be central—because stigma, gender-based violence, and punitive laws still block millions from care.
For 25 years, the world questioned whether Africa could deliver on HIV. It did. Now, the question is whether the world will back Africa to finish the job—on African terms.